+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Use of unproven therapies by people with Alzheimer's disease



Use of unproven therapies by people with Alzheimer's disease



Journal of the American Geriatrics Society 43(7): 747-750



OBJECTIVE: To describe the use of unproven therapies for Alzheimer's disease. DESIGN: Descriptive survey using a written questionnaire. PARTICIPANTS: 101 primary caregivers of people with Alzheimer's disease who attended Alzheimer's disease support group meetings. RESULTS: Fifty-five percent of caregivers reported that they had tried at least one alternative therapy to improve the patient's memory. Twenty percent of caregivers tried three or more unproven therapies, Vitamins were used most frequently (84%), and health foods (27%), herbal medicines (11%), "smart pills" (9%), and home remedies (7%) were also tried. Most caregivers reported trying the therapies in the early stage of the illness and did not notice significant improvement in the patient's memory. Twenty-five percent of caregivers had tried unproven therapies for behavior problems. There was no correlation between the use of alternative therapies and the sex of the caregiver, age of the caregiver, level of caregiver frustration, presence of problem behaviors, or perceived level of physician support. CONCLUSIONS: The use of unproven therapies by people with early Alzheimer's disease is common and cannot be predicted by characteristics of the primary caregiver. Although this use may be understandable, it exposes vulnerable people to possible side effects, increased costs, and possible exploitation. Health care workers should actively inquire about the use of alternative therapies, and explore the reasons behind their use, so that they can better understand and meet the needs of their patients and their caregivers.

(PDF emailed within 0-6 h: $19.90)

Accession: 009702816

Download citation: RISBibTeXText

PMID: 7602024

DOI: 10.1111/j.1532-5415.1995.tb07043.x


Related references

For how long should we use symptomatic therapies to treat people with Alzheimer disease?. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 59(12): 615-617, 2015

Pro: Are we ready to translate Alzheimer's disease modifying therapies to people with Down syndrome?. Alzheimer's Research & Therapy 6(5-8): 60-60, 2014

Con: are we ready to translate Alzheimer's disease-modifying therapies to people with down syndrome?. Alzheimer's Research & Therapy 6(5-8): 61-61, 2014

Unproven therapies don't belong in Lyme disease guidelines. Southern Medical Journal 102(10): 1088-9; Author Reply 1089-91, 2009

Perspectives on future Alzheimer therapies: amyloid-β protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer's disease. Alzheimer's Research & Therapy 6(2): 16-16, 2014

Which medical and social decision topics are important after early diagnosis of Alzheimer's Disease from the perspectives of people with Alzheimer's Disease, spouses and professionals?. Bmc Research Notes 9(): 149-149, 2016

The value of vitamin E as a treatment for Alzheimer's disease remains unproven despite functional improvement, due to a lack of established effect on cognition or other outcomes from RCTs. Evidence-Based Medicine 19(4): 140-140, 2015

Unproven therapies. Diabetes Care 23 Suppl 1: S110-S110, 2002

An intergenerational choir formed to lessen Alzheimer's disease stigma in college students and decrease the social isolation of people with Alzheimer's disease and their family members: a pilot study. American Journal of Alzheimer's Disease and Other Dementias 29(3): 270-281, 2015

Unproven cancer therapies. American Pharmacy Ns28(2): 18-22, 1988

The pitfall of unproven therapies. Journal of School Health 49(7): 421-421, 1979

Unproven cancer therapies in finland. Journal of Cancer Research & Clinical Oncology 116(SUPPL PART 1): 636, 1990

Unproven Therapies for Diabetes and Their Implications. Advances in Therapy (): -, 2016

Unproven therapies in the treatment of cancer. Journal of the National Cancer Institute 84(22): 1757-1758, 1992

Cancer, unproven therapies, and magic. Oncology 14(9): 1345-50; Discussion 1355-9, 2000